Bharat Parenterals Limited was formed under the chairmanship of Mr. Ramesh Desai and incorporated as Limited Company on 3rd September 1992. The company has grown steadily from a humble beginning, to a position of strength under the stewardship of Mr. Bharat R. Desai, a visionary. The company has a portfolio of over 800 products spread over more than 20 different therapeutical categories. Our WHO-GMP manufacturing unit is accredited further as a 2 Star Export House. We are the trusted partner of 60+ clients exporting to 15+ countries in semi-regulated & ROW markets. What differentiates us from the plethora of Indian contract manufacturing services providers is our DSIR Approved Formulation R&D Centre for Excellence that is constantly engaging in the development of optimized & innovative formulations. At our core manufacturing facility are 3 units each dedicated to the development of – General, Cephalosporin, and B-Lactam drug formulations. A publicly traded company on the BSE, in over 3 decades of its existence, the company driven with its core values & on an aggressive pursuit of organic growth now serves as parent company to 3 dynamic and growing organizations: Varenyam Healthcare Private Limited: The domestic marketing arm of Varenyam with a team of over 200 Medical Sales professions, marketing branded formulations in niche therapy area of anaesthesia & critical care. Varenyam Bio-Lifesciences: A progressive manufacturing unit dedicated to niche formulations such as PFS, emulsion injectables & other injectables, proposed to be accredited by EU- GMP and other semi-regulated region’s bodies. Innoxel Lifesciences Limited: A first of its kind US FDA - manufacturing unit in India embarking upon a journey of pioneering advancement of Health with futuristic patient centric treatment solutions.